{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:48:11Z","timestamp":1794001691484,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.heliyon.2025.e41965","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T13:32:37Z","timestamp":1737466357000},"page":"e41965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fatal toxoplasmic encephalitis triggered by anti-TNF therapy"],"prefix":"10.1016","volume":"11","author":[{"given":"Rodrigo A.","family":"Montoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Overmyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Periaccante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Coon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Lanjewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0454-895X","authenticated-orcid":false,"given":"Rob","family":"Striker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2025.e41965_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.heliyon.2025.e41965_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","article-title":"Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry","volume":"70","author":"Salmon-Ceron","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2025.e41965_bib3","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2025.e41965_bib4","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.4049\/jimmunol.170.12.6172","article-title":"Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system","volume":"170","author":"Schl\u00fcter","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2025.e41965_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02822","article-title":"Risk assessment of etanercept in mice chronically infected with Toxoplasma gondii","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2025.e41965_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00277-003-0705-2","article-title":"Cerebral toxoplasmosis following etanercept treatment for idiophatic pneumonia syndrome after autologous peripheral blood progenitor cell transplantation (PBPCT)","volume":"82","author":"Gonzalez-Vicent","year":"2003","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.heliyon.2025.e41965_bib7","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1056\/NEJMc051556","article-title":"Infliximab and reactivation of cerebral toxoplasmosis","volume":"353","author":"Young","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2025.e41965_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.semarthrit.2006.08.004","article-title":"Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis","volume":"36","author":"Lassoued","year":"2007","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.heliyon.2025.e41965_bib9","first-page":"1","article-title":"Effects of Toxoplasma gondii infection on cognition, symptoms, and response to digital cognitive training in schizophrenia","volume":"8","author":"Guimar\u00e3es","year":"2022","journal-title":"Schizophr"},{"key":"10.1016\/j.heliyon.2025.e41965_bib10","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1038\/s41467-023-38238-6","article-title":"Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection","volume":"14","author":"Ahuja","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2025.e41965_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00052","article-title":"Diversity of Toxoplasma gondii strains at the global level and its determinants","volume":"15","author":"Galal","year":"2019","journal-title":"Food and Waterborne Parasitology"},{"key":"10.1016\/j.heliyon.2025.e41965_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ijpara.2011.01.005","article-title":"Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America","volume":"41","author":"Khan","year":"2011","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.heliyon.2025.e41965_bib13","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1128\/JCM.43.12.5881-5887.2005","article-title":"Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains","volume":"43","author":"Khan","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2025.e41965_bib14","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/cid\/ciaa285","article-title":"Toxoplasmosis outbreak associated with Toxoplasma gondii-contaminated venison\u2014high attack rate, unusual clinical presentation, and atypical genotype","volume":"72","author":"Schumacher","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2025.e41965_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.parint.2013.06.008","article-title":"Isolation of Toxoplasma gondii strains similar to Africa 1 genotype in Turkey","volume":"62","author":"D\u00f6\u015fkaya","year":"2013","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.heliyon.2025.e41965_bib16","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1021\/acs.analchem.7b04808","article-title":"Improved precursor characterization for data-dependent mass spectrometry","volume":"90","author":"Hebert","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.heliyon.2025.e41965_bib17","doi-asserted-by":"crossref","first-page":"11503","DOI":"10.1021\/acs.analchem.8b02766","article-title":"Ultra-high pressure (>30,000 psi) packing of capillary columns enhancing depth of shotgun proteomic analyses","volume":"90","author":"Shishkova","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.heliyon.2025.e41965_bib18","article-title":"Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease","volume":"15","author":"McKetney","year":"2021","journal-title":"Proteonomics Clin. Appl."},{"key":"10.1016\/j.heliyon.2025.e41965_bib19","article-title":"Performance of polymerase chain reaction analysis of the amniotic fluid of pregnant women for diagnosis of congenital toxoplasmosis: a systematic review and meta-analysis","volume":"11","author":"Azevedo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2025.e41965_bib20","article-title":"Cerebral toxoplasmosis in a rheumatoid arthritis patient on immunosuppressive therapy","volume":"12","author":"Hill","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.heliyon.2025.e41965_bib21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/brainsci12081050","article-title":"Cerebral toxoplasmosis as an uncommon complication of biologic therapy for rheumatoid arthritis: case report and review of the literature","volume":"12","author":"de Almeida","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.heliyon.2025.e41965_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.idcr.2016.06.006","article-title":"Cerebral toxoplasmosis and anti-TNF\u03b1: a case report","volume":"5","author":"Cren","year":"2016","journal-title":"IDCases"},{"key":"10.1016\/j.heliyon.2025.e41965_bib23","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2169\/internalmedicine.54.3977","article-title":"Cerebral toxoplasmosis in a patient on methotrexate and infliximab for rheumatoid arthritis","volume":"54","author":"Pulivarthi","year":"2015","journal-title":"Intern. Med."},{"key":"10.1016\/j.heliyon.2025.e41965_bib24","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.cmi.2017.12.025","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-\u03b1 agents)","volume":"24","author":"Baddley","year":"2018","journal-title":"Clin. Microbiol. Infection"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025003457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025003457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:45:47Z","timestamp":1775738747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844025003457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2405844025003457"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41965","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatal toxoplasmic encephalitis triggered by anti-TNF therapy","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e41965"}}